Page last updated: 2024-12-09
glucoiberin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
glucoiberin: from Iberis amara; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Iberis | genus | [no description available] | Brassicaceae | A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. They are mostly herbaceous plants with peppery-flavored leaves, due to gluconapin (GLUCOSINOLATES) and its hydrolysis product butenylisotrhiocyanate. The family includes many plants of economic importance that have been extensively altered and domesticated by humans. Flowers have 4 petals. Podlike fruits contain a number of seeds. Cress is a general term used for many in the Brassicacea family. Rockcress is usually ARABIS; Bittercress is usually CARDAMINE; Yellowcress is usually RORIPPA; Pennycress is usually THLASPI; Watercress refers to NASTURTIUM; or RORIPPA or TROPAEOLUM; Gardencress refers to LEPIDIUM; Indiancress refers to TROPAEOLUM.[MeSH] |
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9548622 |
| MeSH ID | M0428089 |
Synonyms (11)
| Synonym |
|---|
| beta-d-glucopyranose, 1-thio-, 1-(4-(methylsulfinyl)-n-(sulfooxy)butanimidate) |
| 554-88-1 |
| glucoiberin |
| 46v6r5sr5v , |
| unii-46v6r5sr5v |
| 3-(methylsulfinyl)propyl glucosinolate |
| 3-(methylsulfinyl)propylglucosinolate |
| glucoiberin , hplc grade |
| mfcd09752807 |
| [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-4-methylsulfinyl-n-sulfooxybutanimidothioate |
| glucoiberin(rg) |
Research Excerpts
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| "For the first time, the effect of residual MYR activity on isothiocyanate bioavailability was systematically and quantitatively studied." | ( In vivo formation and bioavailability of isothiocyanates from glucosinolates in broccoli as affected by processing conditions. Dekker, M; Oliviero, T; Verkerk, R; Vermeulen, M, 2014) | 0.4 |
| "Optimization of bioavailability of dietary bioactive health-beneficial compounds is as important as increasing their concentration in foods." | ( Bioavailability of Isothiocyanates From Broccoli Sprouts in Protein, Lipid, and Fiber Gels. Capuano, E; Dekker, M; Lamers, S; Oliviero, T; Verkerk, R, 2018) | 0.48 |
| " Samples in which sulforaphane and iberin were preformed by myrosinase led to a higher bioavailability of those compounds." | ( Bioavailability of Isothiocyanates From Broccoli Sprouts in Protein, Lipid, and Fiber Gels. Capuano, E; Dekker, M; Lamers, S; Oliviero, T; Verkerk, R, 2018) | 0.48 |
| "This explorative study suggests that ITCs bioavailability can be modulated by food structure and composition and further and deeper investigations are needed to develop food products that lead to an optimized ITCs bioavailability." | ( Bioavailability of Isothiocyanates From Broccoli Sprouts in Protein, Lipid, and Fiber Gels. Capuano, E; Dekker, M; Lamers, S; Oliviero, T; Verkerk, R, 2018) | 0.48 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Pathways (1)
| Pathway | Proteins | Compounds |
|---|---|---|
| glucosinolate biosynthesis from homomethionine | 6 | 29 |
Research
Studies (17)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (5.88%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (94.12%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||